Report assesses implementation of NICE guidance
NICE has published a report examining progress made by the healthcare system in implementing its guidance.
The ‘NICEimpact diabetes’ reviews how the organisation’s recommendations for evidence-based and cost-effective care are being used in priority areas of the health and care system to improve outcomes.
It states: “We routinely collect data which give us information about the uptake of our guidance. To produce this report, we have worked with national partners to select data which tell us how NICE guidance can make a difference in priority areas relating to diabetes. The data also highlight areas where there remains room for improvement.”
The report focuses on preventing type 2 diabetes, where it discusses the Healthier You: NHS Diabetes Prevention Programme (NDPP), and managing diabetes, examining the nine care processes, including eye screening. There is also a spotlight on insulin pump therapy.
In an accompanying commentary, Diabetes UK Chief Executive Chris Askew said: “NICE guidance is like a foundation stone in the diabetes system. Clinical audits, the Quality and Outcomes Framework, the diabetes part of the CCG Improvement and Assessment Framework, the NHS RightCare diabetes pathway all build upon NICE’s trusted guidance.”
Speaking about the NDPP, he added: “One of the most heartening parts of diabetes in the last few years has been the extraordinary progress of the NHS Diabetes Prevention Programme. This is on course to reach 100,000 people a year by 2020 and early results show that it is having the effects on weight loss and take-up that we hoped for at the outset.
“Meanwhile the programme is reaching more men than weight loss programmes normally reach and reflects the ethnic make-up of the population. As a full partner in the programme we are not complacent but the evidence so far is encouraging.”
To access the report, click here.